Skip to main content
. 2020 Oct 13;27(2):284–290. doi: 10.1016/j.jiac.2020.10.013

Table 2.

Primary treatment regimen.

Mild disease (n = 46)
 No treatment 3
 CIC 30
 FPV + CIC
13
Moderate disease (n = 9)
 No treatment 1
 CIC 1
 FPV 1
 FPV + CIC 4
 FPV + HCQ 1
 FPV + CIC + HCQ
1
Severe disease (n = 17)
 FPV 4
 FPV + CIC 2
 FPV + HCQ 6
 FPV + TCZ 5

CIC, ciclesonide; FPV, favipiravir; HCQ, hydroxychloroquine; TCZ, tocilizumab.